Carbon Reduction Plan
Reporting period 1 April 2025 to 31 March 2026 · Published 1 October 2026
Commitment to achieving net zero
WeAreRiSE Limited is committed to achieving net zero greenhouse gas emissions by 2050 for its UK operations, covering Scope 1, Scope 2 and the five Scope 3 categories required by the applicable NHS Carbon Reduction Plan standard.
Business and reporting boundary
WeAreRiSE Limited provides clinical services at host hospitals. This plan covers its UK operations for the year ended 31 March 2026, using the operational-control approach.
Host hospitals provide and manage their premises, clinical equipment, medical gases, consumables and clinical waste arrangements. Host-controlled operations are outside RiSE’s Scope 1 and Scope 2 reporting boundary.
RiSE had no owned or rented office premises during the reporting year. Optional homeworking energy emissions are excluded. The inventory includes company-controlled vehicle fuel and electricity consumption and the relevant Scope 3 categories. Vehicle consumption includes commuting and private use, avoiding double counting.
Baseline and current emissions
The year ended 31 March 2026 is the initial baseline and current reporting year. Figures are expressed in tonnes of carbon dioxide equivalent (tCO2e).
| Emissions category | Baseline 2025/26 | Current 2025/26 |
|---|---|---|
| Scope 1 | 0.43 | 0.43 |
| Scope 2 | 1.19 | 1.19 |
| Scope 3 Category 4 – upstream transport and distribution | 0.01 | 0.01 |
| Scope 3 Category 5 – waste generated in operations | 0.01 | 0.01 |
| Scope 3 Category 6 – business travel | 0.08 | 0.08 |
| Scope 3 Category 7 – employee commuting | 0.00* | 0.00* |
| Scope 3 Category 9 – downstream transport and distribution | 0.00† | 0.00† |
| Total | 1.72 | 1.72 |
* Commuting and private use in company-controlled vehicles are included in vehicle energy consumption, avoiding double counting. No other employee commuting was identified. † Downstream transport and distribution is not applicable to RiSE’s clinical-service model in this reporting period.
Methodology and estimates
Emissions have been estimated in accordance with the GHG Protocol and applicable Carbon Reduction Plan technical standard, using the 2025 UK Government greenhouse gas conversion factors as the principal factor set. Activity data, sources and assumptions are retained in RiSE’s internal calculation record.
Where direct records were unavailable, vehicle emissions were estimated from annual mileage and published efficiency data. The Tesla Model Y was treated as battery-electric; the Mercedes GLC 300 plug-in hybrid was estimated at approximately 90% electric mileage and 10% petrol. Rail travel was estimated from journey distances. Small deliveries and administrative waste used proportionate activity estimates.
A mixed-purpose overseas journey was not treated as wholly RiSE business travel because the underlying journey would have occurred independently; RiSE’s contribution related to an upgrade. Travel by independently engaged clinicians is excluded from employee commuting. Host-managed clinical waste is outside RiSE’s reported waste activity. Assumptions will be reviewed annually.
Reduction targets and measures
Existing practices include electric-vehicle use, largely paperless administration and rail travel for suitable business journeys. No quantified historical emissions saving is claimed in this initial report.
Interim target: reduce reported emissions by at least 10% from the 2025/26 baseline by 31 March 2031, subject to changes in business activity and consistent reporting methodology. This equates to no more than approximately 1.55 tCO2e on a like-for-like basis. Progress will be reviewed annually.
| Measure | Implementation |
|---|---|
| Review lower-emission vehicle options when existing agreements end. | At vehicle renewal |
| Use rail for suitable business journeys and remote meetings where practical. | Ongoing |
| Maintain largely paperless administration and recycle office waste where possible. | Ongoing |
| Maintain proportionate vehicle and travel records, improving estimates where practical. | Ongoing |
| Review emissions and reduction measures and update the plan. | Annually |
These measures apply to RiSE’s administration and service-delivery arrangements where practicable and consistent with clinical requirements. A designated director is responsible for maintaining the plan. The approved plan is published on RiSE’s website and updated at least annually.
Declaration and sign off
This Carbon Reduction Plan has been prepared in accordance with PPN 006, its technical standard and the applicable NHS England guidance. Emissions have been reported using the GHG Protocol and appropriate UK Government conversion factors, covering Scope 1, Scope 2 and the required subset of Scope 3 emissions.
- Approved by the board on
- 1 October 2026
- Signed on behalf of WeAreRiSE Limited by
- Julian Michael Barker, Director
- Date of sign-off
- 1 October 2026